Berberine and Cinnamon in Management of Diabetes
Not Applicable
Completed
- Conditions
- Diabetes
- Interventions
- Other: Placebo (TDS)Dietary Supplement: Berberine+Cinnamon (TDS)
- Registration Number
- NCT05570357
- Lead Sponsor
- National Nutrition and Food Technology Institute
- Brief Summary
In this randomized clinical trial, patients with diabetes will be randomly assigned to receive either Berberine, and Cinnamon supplements or placebo for 12 weeks. Then the glycemic characteristics will be compared in two groups.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 44
Inclusion Criteria
- Age 30-70 years
- Diagnosed type-2 diabetes mellitus (based on American Diabetes Association criteria)
Exclusion Criteria
-
Patients with an allergy to berberine /cinamon
- Lactation, pregnancy
- Patients with any malignancy
- Patients with unrelated chronic illness
- Patients with cardiac, liver or respiratory failure
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Placebo Placebo (TDS) - Intervention Berberine+Cinnamon (TDS) -
- Primary Outcome Measures
Name Time Method HbA1C 0 and 12th week HbA1C change from baseline
- Secondary Outcome Measures
Name Time Method CRP 0 and 12th week measuring the blood concentration of C-reactive protein
Lipid profile 0 and 12th week lipid profiles change from baseline
Anthropometric measurements 0 and 12th week weight, height, BMI, WC
Fasting blood sugar 0 and 12th week Blood sugar change from baseline
Blood Pressure 0 and 12th week measuring according to the BP measurement guideline
Trial Locations
- Locations (1)
Azita Hekmatdoost
🇮🇷Tehran, Middle East, Iran, Islamic Republic of